Verana Health Secures $150M in Series C Round to Enhance Real-World Data Insights

Verana Health, a pioneering digital health company, has successfully raised $150 million in a recent funding round aimed at advancing its innovative data analytics solutions for healthcare providers and life sciences organizations. With a robust real-world data network comprising over 20,000 healthcare providers and nearly half a billion de-identified healthcare encounters, Verana Health has positioned itself at the forefront of delivering high-quality insights into drug lifecycles, medical practices, and healthcare society trends. The infusion of capital will be used to enhance their population health data engine, VeraQ™, and expand the scope of their disease-specific data sets, known as Qdata™. These tools facilitate out-of-the-box data analytics informed by real-world evidence, empowering not just the top pharmaceutical companies, but also bolstering the quality reporting efforts of healthcare providers participating in Medicare's MIPS program. With this funding, Verana Health is set to further optimize its offerings, ensuring that healthcare providers can make informed decisions based on real-world evidence, ultimately leading to improved patient outcomes. This investment signifies a critical step in Verana Health’s mission to enhance healthcare delivery through advanced analytics and accessible data solutions, marking an exciting chapter in its growth and a continued commitment to innovation in the healthcare landscape.